Paradromics, a neurotech startup rivaling Elon Musk's Neuralink, successfully implanted and removed its brain-computer interface device during human surgery, marking a major milestone as it prepares for broader clinical trials to help people with severe motor impairments like paralysis.
The FDA's new AI tool for reviewing medical devices, CDRH-GPT, is struggling with basic tasks like uploading documents and accessing recent studies, raising concerns about rushing AI adoption before it's ready to handle complex regulatory work accurately and safely.
Neurotech startup Paradromics has achieved a major milestone by successfully implanting its brain-computer interface in a human for the first time, paving the way for a clinical trial later this year to study the long-term safety and use of its technology.
In a groundbreaking medical milestone, Paradromics, a brain-computer interface startup, successfully implanted and safely removed its brain implant, Connexus, from a human patient for the first time, paving the way for restoring speech and communication for those with paralysis.
The FDA has granted De Novo authorization to Clairity Breast, the first AI-powered platform that predicts a woman's risk of developing breast cancer over the next five years using only a standard mammogram, paving the way for more personalized and equitable breast cancer prevention and care.
Early AI investor Elad Gil is now betting big on using AI to transform traditional businesses through roll-ups, acquiring mature companies and using AI to radically increase their margins, then repeating the process to create tech-enabled giants in industries like legal services.
A new AI test can identify which men with high-risk prostate cancer will benefit most from the life-extending drug abiraterone, potentially saving lives and NHS costs by avoiding unnecessary treatment for those unlikely to benefit.
In a groundbreaking move, the FDA has announced an aggressive timeline to integrate AI across all centers by June 30, 2025, following a successful pilot that significantly reduced scientific review times from days to minutes, promising to accelerate the approval process for new therapies.
A panel of health leaders warns that by 2050, an alarming 1.3 billion people could have diabetes and over 5 billion may be insulin resistant, but AI technology tracking food composition and personalized health data offers hope for prevention and early intervention.
A creepy-looking AI robot nurse called Nurabot has been unveiled to tackle healthcare worker burnout by patrolling hospital halls, delivering medicine, tracking vitals, and potentially assisting with patient care tasks like lifting in the future.